Company: SHPH
Filing Date: 2025-02-13
Form Type: S-1
Source: 0001493152-25-006202
Chunk: 166

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-13
Form: S-1
Chunk 166
---
 |     |               |           - |   |     |              |           - |   |
| Common stock, $0.00001 par value; 100,000,000 shares authorized; 2,946,099 and 2,008,689 
 shares issued and outstanding, respectively                                              |     |               |          29 |   |     |              |          20 |   |
| Additional paid in capital                                                               |     |               |  31,664,226 |   |     |              |  29,489,055 |   |
| Accumulated deficit                                                                      |     |               | (32,979,632 | ) |     |              | (25,433,304 | ) |
| Total Stockholders’ Equity (Deficit)                                                     |     |               |  (1,315,377 | ) |     |              |   4,055,771 |   |
| Total Liabilities and Stockholders’ Equity (Deficit)                                     |     | $             |     673,568 |   |     | $            |   5,951,736 |   |

<div align='center'>The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</div>

| F-2 |

<div align='center'>Shuttle Pharmaceuticals Holdings, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)</div>

|                                                                                                               |     |               2024 |            |   |     | 2023 |            |   |     |              2024 |            |   |     | 2023 |            |   |
|                                                                                                               |     | Three Months Ended |            |   |     |      |            |   |     | Nine Months Ended |            |   |     |      |            |   |
|                                                                                                               |     |      September 30, |            |   |     |      |            |   |     |     September 30, |            |   |     |      |            |   |
|                                                                                                               |     |               2024 |            |   |     | 2023 |            |   |     |              2024 |            |   |     | 2023 |            |   |
| Revenue                                                                                                       |     |                  $ |          - |   |     |    $ |          - |   |     |                 $ |          - |   |     |    $ |          - |   |
| Operating expenses